| DEMOGRAPHICS and O2 |
Age |
M/F ratio |
pk yr |
BMI |
Exac Prev Yr |
Oxygen use |
| High Risk (n=16) |
60.2(9.5) |
10/6 |
59.1(30.6) |
26.1(3.5) |
0.50(0.61) |
5/16 |
| Low Risk (n=13) |
61.3(7.0) |
9/4 |
36.8(19.4) |
24.5(3.3) |
0.77(0.72) |
5/13 |
| p |
0.76 |
|
0.02 |
0.35 |
0.14 |
|
| MEDICATION USE |
SABA |
LABA |
SAAC |
LAAC |
ICS |
Phosphodisterase Inhibitor |
| High Risk (n=16) |
12.5% |
81.3% |
0,00% |
87.5% |
68.8% |
6.3% |
| Low Risk (n=13) |
23.1% |
100.00% |
15.3% |
69.2% |
92.3% |
15.3% |
| p |
|
|
|
|
|
|
| Baseline physiology |
Baseline RV (% pred) |
RV/TLC |
FEV1 (% pred) |
DLco (% pred) |
6 MWT (meters) |
MRCD (units) |
BODE index |
| High Risk (n=16) |
216.5(66.3) |
0.61(0.11) |
35.1(9.1) |
40.8(18.4) |
345(123) |
3.0(0.5) |
5.4(1.6) |
| Low Risk (n=13) |
233.6(68.3) |
0.61(0.13) |
30.3(6.7) |
37.8(19.0) |
353(120) |
3.0(0.5) |
5.7(1.2) |
| p |
0.46 |
0.95 |
0.09 |
0.69 |
0.88 |
1.0 |
0.52 |
|
